Future research into molecular mechanisms for muscle loss and intervention strategies to correct the effects of dysregulated MEF2C would greatly enhance our understanding of cancer cachexia progression and ultimately benefit cancer patient quality of life by improving muscle strength. The gene discussed is MEF2C; the disease is cancer.